Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors
- PMID: 4024395
- DOI: 10.1007/BF00256074
Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors
Abstract
Serum levels of fucosyltransferase (FT), phosphohexoseisomerase (PHI), tissue polypeptide antigen (TPA), Tennessee antigen (TAG), carcinoembryonic antigen (CEA) and prostatic acid phosphate (PAP) were determined in 75 healthy individuals and in 86 patients with prostatic carcinoma and 38 patients with bladder tumors. The discrimination capacities of the different markers were compared by using inverse distribution plots. At a rate of 5% false positive values the sensitivities for bladder tumors were: FT 30%, TPA 24%, CEA 16%, TAG 15%. The sensitivities for prostatic carcinoma were: PAP 63%, PHI 36%, TPA 18%, CEA 14%, TAG 14%.
Similar articles
-
Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.Int Urol Nephrol. 1988;20(2):123-9. doi: 10.1007/BF02550661. Int Urol Nephrol. 1988. PMID: 2454895
-
Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.Anticancer Res. 1993 May-Jun;13(3):769-77. Anticancer Res. 1993. PMID: 7686362
-
Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.Cancer Detect Prev. 1987;10(3-4):197-203. Cancer Detect Prev. 1987. PMID: 3568016
-
TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.Am J Clin Oncol. 1996 Jun;19(3):271-7. doi: 10.1097/00000421-199606000-00013. Am J Clin Oncol. 1996. PMID: 8638540
-
Biochemical markers in prostatic cancer.Urol Clin North Am. 1984 May;11(2):253-67. Urol Clin North Am. 1984. PMID: 6203205 Review.
Cited by
-
Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.J Cancer Res Clin Oncol. 1992;118(8):626-8. doi: 10.1007/BF01211809. J Cancer Res Clin Oncol. 1992. PMID: 1517284 Free PMC article.
-
Serum tissue polypeptide antigen (TPA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.Int Urol Nephrol. 1988;20(2):123-9. doi: 10.1007/BF02550661. Int Urol Nephrol. 1988. PMID: 2454895
References
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials